These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8019790)

  • 1. Decrease in detectable complement receptor type 1 levels on erythrocytes from patients with psoriatic polyarthritis.
    Rivas D; Riestra-Noriega JL; Torre-Alonso JC; Rodriguez A; Gutiérrez C
    Br J Rheumatol; 1994 Jul; 33(7):626-30. PubMed ID: 8019790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy.
    Corvetta A; Pomponio G; Bencivenga R; Luchetti MM; Spycher M; Spaeth PJ; Danieli G
    J Rheumatol; 1991 Jul; 18(7):1021-5. PubMed ID: 1833542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement C3b receptors on erythrocytes in patients with juvenile rheumatoid arthritis.
    Thomsen BS; Heilmann C; Jacobsen SE; Pedersen FK; Morling N; Jakobsen BK; Svejgaard A; Nielsen H
    Arthritis Rheum; 1987 Sep; 30(9):967-71. PubMed ID: 2959290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does reduced erythrocyte C3b receptor (CR1) activity contribute to the pathogenesis of yersinia triggered reactive arthritis?
    Lahesmaa R; Eerola E; Toivanen A
    Ann Rheum Dis; 1992 Jan; 51(1):97-100. PubMed ID: 1531747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal distribution of complement C3b receptor (CR1) numbers on erythrocytes in blood donors: low levels are associated with HLA-B27.
    Thomsen BS; Jacobsen SE; Nielsen H; Jakobsen BK; Sørensen H
    Complement; 1986; 3(2):79-87. PubMed ID: 2945696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cartilage collagen type II seromarker patterns in axial spondyloarthritis and psoriatic arthritis: associations with disease activity, smoking and HLA-B27.
    Munk HL; Gudmann NS; Christensen AF; Ejstrup L; Sorensen GL; Loft AG; Bay-Jensen AC; Siebuhr AS; Junker P
    Rheumatol Int; 2016 Apr; 36(4):541-9. PubMed ID: 26620690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus.
    Iida K; Mornaghi R; Nussenzweig V
    J Exp Med; 1982 May; 155(5):1427-38. PubMed ID: 6978375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lowered expression of C3b receptor (CR1) on erythrocytes of rheumatoid arthritis patients.
    Kumar A; Malaviya AN; Srivastava LM
    Immunobiology; 1994 Aug; 191(1):9-20. PubMed ID: 7806259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered erythrocyte CR1 binding kinetics compensate for decreased binding capacity in rheumatoid arthritis.
    Hargrove JK; Meryhew NL; Runquist OA
    J Clin Chem Clin Biochem; 1990 Aug; 28(8):533-41. PubMed ID: 2147952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synovitis-acne-pustulosis-hyperostosis-osteitis syndrome and psoriatic arthritis exhibit a different immunogenetic profile.
    Queiro R; Moreno P; Sarasqueta C; Alperi M; Riestra JL; Ballina J
    Clin Exp Rheumatol; 2008; 26(1):125-8. PubMed ID: 18328159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced numbers of complement receptor type 1 on erythrocytes are associated with increased levels of anticardiolipin antibodies. Findings in patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Hammond A; Rudge AC; Loizou S; Bowcock SJ; Walport MJ
    Arthritis Rheum; 1989 Mar; 32(3):259-64. PubMed ID: 2522783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple method for accurate quantification of complement receptor 1 on erythrocytes preserved by fixing or freezing.
    Cockburn IA; Donvito B; Cohen JH; Rowe JA
    J Immunol Methods; 2002 Dec; 271(1-2):59-64. PubMed ID: 12445729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of complement 3 receptors (CR1 and CR3) on neutrophils and erythrocytes in patients with IgA nephropathy.
    Tao K; Nicholls K; Rockman S; Kincaid-Smith P
    Clin Nephrol; 1989 Nov; 32(5):203-8. PubMed ID: 2684457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to Klebsiella, Proteus, and HLA-B27 peptides in Japanese patients with ankylosing spondylitis and rheumatoid arthritis.
    Tani Y; Tiwana H; Hukuda S; Nishioka J; Fielder M; Wilson C; Bansal S; Ebringer A
    J Rheumatol; 1997 Jan; 24(1):109-14. PubMed ID: 9002020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A flow cytometric assay for measuring complement receptor 1 (CR1) and the complement fragments C3d and C4d on erythrocytes.
    Freysdottir J; Sigfusson A
    J Immunol Methods; 1991 Aug; 142(1):45-52. PubMed ID: 1833467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of erythrocyte complement receptors (CR1; CD35) in patients with acute episodes of septicaemia or bacterial meningitis.
    Olesen B; Thomsen BS; Kristensen HS
    Scand J Infect Dis; 1992; 24(2):189-95. PubMed ID: 1641596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower level of synovial fluid interferon-gamma in HLA-B27-positive than in HLA-B27-negative patients with Chlamydia trachomatis reactive arthritis.
    Bas S; Kvien TK; Buchs N; Fulpius T; Gabay C
    Rheumatology (Oxford); 2003 Mar; 42(3):461-7. PubMed ID: 12626797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement receptor (CR1) and IgG or IgA on erythrocytes and in circulating immune complexes in patients with glomerulonephritis.
    Coppo R; Amore A; Roccatello D; Amoroso A; Maffei S; Quattrocchio G; Molino A; Gianoglio B; Piccoli G
    Nephrol Dial Transplant; 1989; 4(11):932-8. PubMed ID: 2516882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
    Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
    J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation-Induced Killer Cell Immunoglobulin-like Receptor 3DL2 Binding to HLA-B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis.
    Ridley A; Hatano H; Wong-Baeza I; Shaw J; Matthews KK; Al-Mossawi H; Ladell K; Price DA; Bowness P; Kollnberger S
    Arthritis Rheumatol; 2016 Apr; 68(4):901-14. PubMed ID: 26841353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.